Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint Infections
<i>Staphylococcus aureus</i> frequently causes community- and hospital-acquired infections. <i>S. aureus</i> attachment followed by biofilm formation on tissues and medical devices plays a significant role in the establishment of chronic infections. Staphylococcal biofilms en...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/9/1060 |
id |
doaj-469722bcaaa3447bbd5ffd6530868d09 |
---|---|
record_format |
Article |
spelling |
doaj-469722bcaaa3447bbd5ffd6530868d092021-09-25T23:36:54ZengMDPI AGAntibiotics2079-63822021-09-01101060106010.3390/antibiotics10091060Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint InfectionsNarayan Pant0Damon P. Eisen1College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, AustraliaCollege of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia<i>Staphylococcus aureus</i> frequently causes community- and hospital-acquired infections. <i>S. aureus</i> attachment followed by biofilm formation on tissues and medical devices plays a significant role in the establishment of chronic infections. Staphylococcal biofilms encase bacteria in a matrix and protect the cells from antimicrobials and the immune system, resulting in infections that are highly resistant to treatment. The biology of biofilms is complex and varies between organisms. In this review, we focus our discussion on <i>S. aureus</i> biofilms and describe the stages of their formation. We particularly emphasize genetic and biochemical processes that may be vulnerable to novel treatment approaches. Against this background, we discuss treatment strategies that have been successful in animal models of <i>S. aureus</i> biofilm-related infection and consider their possible use for the prevention and eradication of biofilm-related <i>S. aureus</i> prosthetic joint infection.https://www.mdpi.com/2079-6382/10/9/1060non-antimicrobial adjuvantbiofilm<i>Staphylococcus aureus</i>prosthetic joint infections |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Narayan Pant Damon P. Eisen |
spellingShingle |
Narayan Pant Damon P. Eisen Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint Infections Antibiotics non-antimicrobial adjuvant biofilm <i>Staphylococcus aureus</i> prosthetic joint infections |
author_facet |
Narayan Pant Damon P. Eisen |
author_sort |
Narayan Pant |
title |
Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint Infections |
title_short |
Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint Infections |
title_full |
Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint Infections |
title_fullStr |
Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint Infections |
title_full_unstemmed |
Non-Antimicrobial Adjuvant Strategies to Tackle Biofilm-Related <i>Staphylococcus aureus</i> Prosthetic Joint Infections |
title_sort |
non-antimicrobial adjuvant strategies to tackle biofilm-related <i>staphylococcus aureus</i> prosthetic joint infections |
publisher |
MDPI AG |
series |
Antibiotics |
issn |
2079-6382 |
publishDate |
2021-09-01 |
description |
<i>Staphylococcus aureus</i> frequently causes community- and hospital-acquired infections. <i>S. aureus</i> attachment followed by biofilm formation on tissues and medical devices plays a significant role in the establishment of chronic infections. Staphylococcal biofilms encase bacteria in a matrix and protect the cells from antimicrobials and the immune system, resulting in infections that are highly resistant to treatment. The biology of biofilms is complex and varies between organisms. In this review, we focus our discussion on <i>S. aureus</i> biofilms and describe the stages of their formation. We particularly emphasize genetic and biochemical processes that may be vulnerable to novel treatment approaches. Against this background, we discuss treatment strategies that have been successful in animal models of <i>S. aureus</i> biofilm-related infection and consider their possible use for the prevention and eradication of biofilm-related <i>S. aureus</i> prosthetic joint infection. |
topic |
non-antimicrobial adjuvant biofilm <i>Staphylococcus aureus</i> prosthetic joint infections |
url |
https://www.mdpi.com/2079-6382/10/9/1060 |
work_keys_str_mv |
AT narayanpant nonantimicrobialadjuvantstrategiestotacklebiofilmrelatedistaphylococcusaureusiprostheticjointinfections AT damonpeisen nonantimicrobialadjuvantstrategiestotacklebiofilmrelatedistaphylococcusaureusiprostheticjointinfections |
_version_ |
1717368442348109824 |